Trial Outcomes & Findings for A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG (NCT NCT03723590)

NCT ID: NCT03723590

Last Updated: 2023-09-06

Results Overview

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

5 participants

Primary outcome timeframe

Baseline to 42 days

Results posted on

2023-09-06

Participant Flow

Participant milestones

Participant milestones
Measure
Esterified Hyaluronic Acid Matrix
Esterified Hyaluronic Acid Matrix: A non-woven pad composed of esterified hyaluronic acid, covered with a semipermeable silicone layer to protect the wound and control water vapor loss
Overall Study
STARTED
5
Overall Study
COMPLETED
0
Overall Study
NOT COMPLETED
5

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: Baseline to 42 days

Population: Study was stopped due to business decision and data was not collected for analysis.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline to 42 days

Population: Study was stopped due to business decision and data was not collected for analysis.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline to 42 days

Population: Study was stopped due to business decision and data was not collected for analysis.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline to 42 days

Population: Study was stopped due to business decision and data was not collected for analysis.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 28 days

Population: Study was stopped due to business decision and data was not collected for analysis.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline to 70 days

Population: Study was stopped due to business decision and data was not collected for analysis.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline to 70 days

Population: Study was stopped due to business decision and data was not collected for analysis.

The facility that the subject is discharged to will be captured.

Outcome measures

Outcome data not reported

Adverse Events

Esterified Hyaluronic Acid Matrix

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Julie Miller

Medline Industries

Phone: 630-418-6891

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place